Safety Profile of Amnion-Derived Cellular Cytokine Solution (ACCS) Following Topical Skin Application in Patients Receiving Breast Radiotherapy.

about

Safety Profile of Amnion-Derived Cellular Cytokine Solution (ACCS) Following Topical Skin Application in Patients Receiving Breast Radiotherapy.

Item

http://www.wikidata.org/entity/Q35908320

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@ast

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@en

type

Item

label

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@ast

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@en

prefLabel

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@ast

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy.

@en

P1476

Safety Profile of Amnion-Deriv ...... Receiving Breast Radiotherapy

@en

P2093

D Lawrence Wickerham

http://www.w3.org/2001/XMLSchema#string

David L Steed

http://www.w3.org/2001/XMLSchema#string

Mark Trombetta

http://www.w3.org/2001/XMLSchema#string

Thomas B Julian

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of biologics, lessons learnt from TGN1412

TGN1412: From Discovery to Disaster

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells

PDGF and FGF stimulate wound healing in the genetically diabetic mouse

Scientific and regulatory considerations on the immunogenicity of biologics.

Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factors.

Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.

A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs.

The use of amnion-derived cellular cytokine solution (ACCS) in accelerating closure of interstices in explanted meshed human skin grafts

The effect of amnion-derived cellular cytokine solution on the epithelialization of partial-thickness donor site wounds in normal and streptozotocin-induced diabetic swine

P304

e33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26240671

http://www.w3.org/2001/XMLSchema#string

P932

4522146

http://www.w3.org/2001/XMLSchema#string